BioMed Invest ApS: Financial statements 2014
CVR: 29844925
BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 71,843 and a net result of DKK 708,156 compared with DKK 212,393 the year before. That is a decrease of 6.2% compared with the year before. Equity amounted to DKK 2,556,214. The solvency ratio was 95.3%.
- Gross Profit
- 71,843 kr.
- Profit/Loss
- 708,156 kr.
- Equity
- 2,556,214 kr.
- Total Assets
- 2,683,287 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 72 t. | 708 t. | 2.6 mio. | - |
| 2013 | - | 77 t. | 212 t. | 1.9 mio. | - |
| 2012 | - | 10 t. | 447 t. | 1.8 mio. | - |
Keep an eye on BioMed Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
BioMed Invest ApS has published its annual report for 2013. Gross profit came to DKK 76,626, and the net result was DKK 212,393.
About BioMed Invest ApS
BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.
